loader
report-image

Hunter Syndrome Market Analysis by Severity, by Type, by Complications, by Distribution Channel, by End-Users and by Region: Global Forecast, 2024 - 2033

  • PUBLISHED ON
  • 2024-01-30
  • NO OF PAGES
  • 281
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The Hunter Syndrome market is predicted to develop at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2033, when it is projected to reach USD 2.23 billion, based on an average growth pattern. The market is estimated to reach a value of USD 1.1 billion in 2024.

                                

SOURCE: We Market Research

Hunter Syndrome is a rare genetic condition affecting lysosomal metabolism; it is often referred to as mucopolysaccharidosis II (MPS II). The market for Hunter Syndrome includes medications and treatments created especially for the illness. The syndrome, which is characterized by an insufficiency of the iduronate-2-sulfatase enzyme, causes a build-up of glycosaminoglycans, which eventually damages organs. The industry is driven by novel treatments that try to improve patients' quality of life and reduce symptoms, such as gene and enzyme replacement therapies. Due to its rarity, Hunter Syndrome is a very niche market; nonetheless, continued research and biotechnology developments help to develop new therapeutic approaches for this difficult illness.

The market for Hunter syndrome is being driven by several significant factors, including increased awareness, advancements in diagnostic technologies, and a growing emphasis on research on rare diseases. A deeper understanding of the genetic foundations of Hunter Syndrome has led to heightened research and development activities that have resulted in the creation of targeted medications. In addition, the market has expanded faster as a result of incentives and legislative support for the creation of orphan medications. The increasing collaboration between academic institutions and pharmaceutical businesses fosters innovative therapeutic approaches. Together, these elements propel the market for Hunter Syndrome and support the creation of more useful and affordable treatments for those affected by this rare genetic disorder.

  

Market Scope

Report Attributes

Description

Market Size in 2024

USD 1.1 Billion

Market Forecast in 2033

USD 2.23 Billion

CAGR % 2024-2033

8.2%

Base Year

2023

Historic Data

2016-2022

Forecast Period

2024-2033

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Severity, by Type, by Complications, by Distribution Channel, by End-Users and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

 

Hunter Syndrome Industry: Dynamics & Restrains

Market Drivers

Advancements in Medical Research and Technology - Technological and scientific developments in medicine are driving the Hunter Syndrome market by encouraging novel treatment and diagnostic approaches. Novel technologies such as precision medicine and gene therapy present previously unheard-of prospects for customized therapeutic strategies. Advances in comprehending the genetic foundation of Hunter Syndrome facilitate the creation of tailored treatments, tackling the underlying causes of the condition. Better diagnostic instruments also facilitate early detection, which makes prompt intervention possible and leads to better patient outcomes. In addition to advancing our understanding of Hunter Syndrome, this collaboration between medical research and technology produces real innovations that transform patient care and fuel market expansion.

Increasing Awareness and Diagnosis - A favorable spike in demand for Hunter Syndrome products is being driven by better diagnosis and raised awareness. Increased knowledge of the signs and dangers of Hunter Syndrome is the outcome of increased public awareness campaigns and educational programs. Because of this, a growing number of people and medical professionals are actively looking for an early diagnosis. Early detection promotes better patient outcomes by enabling timely action and access to accessible treatments. In addition to promoting a more knowledgeable and proactive healthcare environment, the combined effects of increased awareness and improved diagnosis also drive the expansion of the Hunter Syndrome market by increasing demand for supportive care and therapeutic interventions.

Market restrains

Lack of Standardized Diagnostic Procedures- There are few recognized diagnostic techniques, which restricts the market for Hunter syndrome. Inconsistencies in the diagnostic process make it harder to reliably and accurately diagnose the illness, which could lead to a delayed or inaccurate diagnosis. Group efforts to gain a better understanding of the condition are hampered by the inability to compare and assess study data due to a lack of standardized techniques. It also makes assessing patient outcomes and therapy efficacy more challenging. To get beyond these limitations, standard diagnostic guidelines must be established. Hunter Syndrome can be diagnosed more precisely by taking care of this issue. Additionally, it encourages effective treatment programs, speeds up research, and eventually aids in market expansion.

We Market Research: Hunter Syndrome Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

                                   


Hunter Syndrome Segmentation

Market- By Severity Analysis

By Type, the Hunter Syndrome Market is Categories into Enzyme Replacement Therapy (ERT), Stem Cell Transplant, Surgical Treatment, Others. The Enzyme Replacement Therapy (ERT) segment accounts for the largest share of around 31% in 2024.

                                   

The Hunter Syndrome market's Enzyme Replacement Therapy (ERT) subsegment is propelled by its focused strategy of restoring missing enzymes and reducing symptoms. The demand for ERT is fueled by its potential to regulate organ dysfunction, lower complications, and enhance patients' quality of life. It is a promising treatment option for those with Hunter Syndrome.

The following segments are part of an in-depth analysis of the global Hunter Syndrome market:

Market Segments

 

By  Severity

·         Mild to Moderate

·         Moderate to Severe

By  Complications

·         Respiratory Disorders

·         Neurological Disorders

·         Gastrointestinal Disorders

·         Cardiovascular

·         Ophthalmic

·         Audiologic

·         Dental

·         Musculoskeletal

·         Others

By End-Users

·         Hospitals

·         Specialty Clinics

·         Others

By Distribution Channel

·         Hospital Pharmacy

·         Retail Pharmacy

·         online Pharmacies

·         Others

 

Hunter Syndrome Industry: Regional Analysis

North America Market Forecast

North America dominate the Hunter Syndrome Market with the highest revenue generating market with share of more than 46%. The market for medications associated with Hunter syndrome is mostly driven by the condition's high prevalence in North America. The market's growth is aided by a supportive regulatory environment, increased awareness, and a sophisticated healthcare infrastructure. Partnerships between pharmaceutical companies and academic institutions, as well as continuous research and development projects, propel the sector forward.

                                   


Europe Market Statistics

Europe is the second-largest market for Hunter Syndrome. Hunter syndrome medicines have found a large market in Europe, driven by factors including a developed healthcare system, more money for research into rare diseases, and an increasing focus on developing orphan drugs. The market is growing because to regulatory incentives for orphan medications as well as increased patient and healthcare professional awareness.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing market for Hunter Syndrome during the forecast period. The Asia-Pacific region presents opportunities for market expansion due to factors such as increased frequency of genetic disorders, improved healthcare infrastructure, and rising healthcare prices. Sales of Hunter syndrome are rising in this region because of large patient bases, untapped markets, and government initiatives to cure rare diseases.

 

Key Market Players

The Hunter Syndrome Market is dominated by a few large companies, such as

·         Takeda Pharmaceutical Company Limited

·         Sangamo Therapeutics

·         Inventiva

·         Green Cross Corp. (GC Pharma)

·         Denali Therapeutics

·         ArmaGen

·         CANbridge Life Sciences Ltd.

·         JCR Pharmaceuticals Co., Ltd.

·         REGENXBIO Inc.

·         Others

Recent Developments:

·         July 2021 – Denali Therapeutics Inc. revealed encouraging results from a clinical trial assessing the ETV: IDS, an investigational brain-penetrant enzyme replacement medication, for the management of peripheral Hunter syndrome symptoms. The results will be presented at the 16th International Symposium on MPS and Related Diseases.

·         May 2021 –The biopharmaceutical business Inventiva has declared that it will take part in the Jefferies Virtual Healthcare Conference.

·         The organization is in charge of creating oral small molecule treatments for unmet needs, including mucopolysaccharidoses (MPS). The company will have an investor meeting and give a corporate overview during this conference.

1.      Global Hunter Syndrome Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Hunter Syndrome Market Scope and Market Estimation

1.2.1. Global Hunter Syndrome Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2033)

1.2.2. Global Hunter Syndrome Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033

1.3.    Market Segmentation

1.3.1. Component of Global Hunter Syndrome Market

1.3.2. Technology of Global Hunter Syndrome Market

1.3.3. Complications of Global Hunter Syndrome Market

1.3.4. Region of Global Hunter Syndrome Market

2.      Executive Summary

2.1.    Global Hunter Syndrome Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Hunter Syndrome Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Hunter Syndrome Market Estimates & Historical Trend Analysis (2019 - 2022)

4.      Global Hunter Syndrome Market Estimates & Forecast Trend Analysis, by TYPE

4.1.    Global Hunter Syndrome Market Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2033

4.1.1. Enzyme Replacement Therapy (ERT)

4.1.2. Stem Cell Transplant

4.1.3. Surgical Treatment

4.1.4. Others

5.      Global Hunter Syndrome Market Estimates & Forecast Trend Analysis, by Severity

5.1.    Global Hunter Syndrome Market Revenue (US$ Mn) Estimates and Forecasts, by Severity, 2019 to 2033

5.1.1. Mild to Moderate

5.1.2. Moderate to Severe

6.      Global Hunter Syndrome Market Estimates & Forecast Trend Analysis, by Complications

6.1.    Global Hunter Syndrome Market Revenue (US$ Mn) Estimates and Forecasts, by Complications, 2019 to 2033

6.1.1. Respiratory Disorders

6.1.2. Neurological Disorders

6.1.3. Gastrointestinal Disorders

6.1.4. Cardiovascular

6.1.5. Ophthalmic

6.1.6. Audiologic

6.1.7. Dental

6.1.8. Musculoskeletal

6.1.9. Others

7.      Global Hunter Syndrome Market Estimates & Forecast Trend Analysis, by END-USERS

7.1.    Global Hunter Syndrome Market Revenue (US$ Mn) Estimates and Forecasts, by Complications, 2019 to 2033

7.1.1. Hospitals

7.1.2. Specialty Clinics

7.1.3. Others

8.      Global Hunter Syndrome Market Estimates & Forecast Trend Analysis, by DISTRIBUTION CHANNEL

8.1.    Global Hunter Syndrome Market Revenue (US$ Mn) Estimates and Forecasts, by Complications, 2019 to 2033

8.1.1. Hospital Pharmacy

8.1.2. Retail Pharmacy

8.1.3. online Pharmacies

8.1.4. Others

9.      Global Hunter Syndrome Market Estimates & Forecast Trend Analysis, by Region

9.1.    Global Hunter Syndrome Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2033

9.1.1. North America

9.1.2. Europe

9.1.3. Asia Pacific

9.1.4. Middle East & Africa

9.1.5. South America

10.  North America Hunter Syndrome Market: Estimates & Forecast Trend Analysis

10.1.      North America Hunter Syndrome Market Assessments & Key Findings

10.1.1.   North America Hunter Syndrome Market Introduction

10.1.2.   North America Hunter Syndrome Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

10.1.2.1.    By TYPE

10.1.2.2.    By Severity

10.1.2.3.    By Complications

10.1.2.4.    By END-USERS

10.1.2.5.    By DISTRIBUTION CHANNEL

10.1.2.6.    By Country

10.1.2.6.1. The U.S.

10.1.2.6.2. Canada

10.1.2.6.3. Mexico

11.  Europe Hunter Syndrome Market: Estimates & Forecast Trend Analysis

11.1.  Europe Hunter Syndrome Market Assessments & Key Findings

11.1.1.   Europe Hunter Syndrome Market Introduction

11.1.2.   Europe Hunter Syndrome Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

11.1.2.1.    By TYPE

11.1.2.2.    By Severity

11.1.2.3.    By Complications

11.1.2.4.    By END-USERS

11.1.2.5.    By DISTRIBUTION CHANNEL

11.1.2.6.    By Country

11.1.2.6.1. Germany

11.1.2.6.2. U.K.

11.1.2.6.3. France

11.1.2.6.4. Italy

11.1.2.6.5. Spain

11.1.2.6.6. Russia

11.1.2.6.7. Rest of Europe

12.  Asia Pacific Hunter Syndrome Market: Estimates & Forecast Trend Analysis

12.1.  Asia Pacific Market Assessments & Key Findings

12.1.1.   Asia Pacific Hunter Syndrome Market Introduction

12.1.2.   Asia Pacific Hunter Syndrome Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

12.1.2.1.    By TYPE

12.1.2.2.    By Severity

12.1.2.3.    By Complications

12.1.2.4.    By END-USERS

12.1.2.5.    By DISTRIBUTION CHANNEL

12.1.2.6.    By Country

12.1.2.6.1. China

12.1.2.6.2. Japan

12.1.2.6.3. India

12.1.2.6.4. Australia

12.1.2.6.5. South Korea

12.1.2.6.6. ASEAN

12.1.2.6.7. Rest of Asia Pacific

13.  Middle East & Africa Hunter Syndrome Market: Estimates & Forecast Trend Analysis

13.1.  Middle East & Africa Market Assessments & Key Findings

13.1.1.   Middle East & Africa Hunter Syndrome Market Introduction

13.1.2.   Middle East & Africa Hunter Syndrome Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

13.1.2.1.    By TYPE

13.1.2.2.    By Severity

13.1.2.3.    By Complications

13.1.2.4.    By END-USERS

13.1.2.5.    By DISTRIBUTION CHANNEL

13.1.2.6.    By Country

13.1.2.6.1. U.A.E.

13.1.2.6.2. Saudi Arabia

13.1.2.6.3. Egypt

13.1.2.6.4. South Africa

13.1.2.6.5. Rest of Middle East & Africa

14.  South America Hunter Syndrome Market: Estimates & Forecast Trend Analysis

14.1.  South America Market Assessments & Key Findings

14.1.1.   South America Hunter Syndrome Market Introduction

14.1.2.   South America Hunter Syndrome Market Size Estimates and Forecast (US$ Million) (2019 – 2033)

14.1.2.1.    By TYPE

14.1.2.2.    By Severity

14.1.2.3.    By Complications

14.1.2.4.    By END-USERS

14.1.2.5.    By DISTRIBUTION CHANNEL

14.1.2.6.    By Country

14.1.2.6.1. Brazil

14.1.2.6.2. Argentina

14.1.2.6.3. Colombia

14.1.2.6.4. Rest of South America

15.  Competition Landscape

15.1.  Global Hunter Syndrome Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

15.2.  Global Hunter Syndrome Market Competition White Space Analysis, By Complications

15.3.  Global Hunter Syndrome Market Competition Heat Map Analysis, By Complications

15.4.  Global Hunter Syndrome Market Concentration & Company Market Shares (%) Analysis, 2022

16.  Company Profiles

16.1.                     Takeda Pharmaceutical Company Limited

16.1.1.   Company Overview & Key Stats

16.1.2.   Financial Performance & KPIs

16.1.3.   Product Portfolio

16.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

16.2.      Sangamo Therapeutics

16.3.      Inventiva

16.4.      Green Cross Corp. (GC Pharma)

16.5.      Denali Therapeutics

16.6.      ArmaGen

16.7.      CANbridge Life Sciences Ltd.

16.8.      JCR Pharmaceuticals Co., Ltd.

16.9.      REGENXBIO Inc.

16.10.  Others

17.  Research Methodology

17.1.  External Transportations / Databases

17.2.  Internal Proprietary Database

17.3.  Primary Research

17.4.  Secondary Research

17.5.  Assumptions

17.6.  Limitations

17.7.  Report FAQs

18.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Hunter Syndrome Market in 2024?

Hunter Syndrome Market was valued at USD 1.1 Billion in 2024.

What is the growth rate for the Hunter Syndrome Market?

Hunter Syndrome Market size will increase at approximate CAGR of 8.2% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Hunter Syndrome Market are Takeda Pharmaceutical Company Limited, Sangamo Therapeutics, Inventiva, Green Cross Corp. (GC Pharma), Denali Therapeutics, ArmaGen, CANbridge Life Sciences Ltd., JCR Pharmaceuticals Co., Ltd., REGENXBIO Inc., Others.

Which region dominates the Hunter Syndrome Market?

North America dominates the market with an active share of 46%.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3750

Only Three Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI